India Inhalation Therapy Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Inhalation Therapy Market was valued at USD 261.0 million in 2025 and is projected to reach USD 408.26 million by 2032, growing at a CAGR of approximately 6.6% during 2026–2032.
India Inhalation Therapy Market Highlights
| Report Metric | Details |
| Report Name | India Inhalation Therapy Market |
| Market Size 2025 | USD 261.0 million |
| Market Size 2032 | USD 408.26 million |
| Absolute Growth 2025–2032 | USD 147.26 million |
| CAGR 2026–2032 | 6.6% |
| Peak Annual Growth | 8.9% in 2027 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Therapy Type, 2025 | Long-Term Therapy (43% share) |
| Leading Drug Category, 2025 | Corticosteroids (41% share) |
| Leading Delivery Setting, 2025 | Outpatient (40% share) |
| Leading Distribution Channel, 2025 | Hospital Supply Chains (36% share) |
| Fastest-Growing Therapy Type | Emergency Therapy (9.3% CAGR) |
| Fastest-Growing Drug Category | Combination Drugs (8.6% CAGR) |
| Fastest-Growing Delivery Setting | Home / Clinic (8.5% CAGR) |
| Fastest-Growing Distribution Channel | Pediatric Clinics (8.5% CAGR) |
| Growing Sector | Healthcare |
| Key End Users | Hospitals, outpatient clinics, senior care facilities, pediatric clinics |
India Inhalation Therapy Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The table below sets out the estimated growth rate for each year and the main factor behind it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 4.1 | The market experienced steady growth, driven by increasing awareness of respiratory health. |
| 2023 | 6.9 | Growth accelerated due to the National Health Mission's initiatives promoting asthma awareness. |
| 2024 | 5.7 | A slight slowdown occurred as the market adjusted to new treatment guidelines. |
| 2025 | 5.0 | Continued growth was noted, supported by rising patient numbers and treatment accessibility. |
| 2026 | 5.6 | Demand increased as emergency services expanded their use of inhalation devices. |
| 2027 | 8.9 | The market peaked with significant growth driven by new product approvals and awareness campaigns. |
| 2028 | 5.4 | Growth slowed as the market began to stabilise after the peak year. |
| 2029 | 4.9 | A further slowdown was observed as the market adjusted to previous growth rates. |
| 2030 | 7.5 | Demand surged again due to new guidelines and increased healthcare investments. |
| 2031 | 8.3 | The market continued to grow, supported by ongoing public health initiatives. |
| 2032 | 5.7 | Growth slowed as the market stabilised, reflecting a mature phase in inhalation therapy. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Inhalation Therapy Market Synopsis
Inhalation Therapy Market in India encompasses the delivery of medication directly to the lungs through devices like nebulizers and inhalers. This therapy plays a crucial role in treating respiratory conditions such as asthma and COPD. The market is expanding due to an increase in patient numbers, with around 30 million asthma patients in 2023, alongside government initiatives aimed at reducing respiratory diseases by 25% by 2025. Greater awareness and accessibility of inhalation devices further fuel demand, especially in urban healthcare settings.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing prevalence of asthma and COPD | Driver | High | Long-Term Therapy |
| Government initiatives promoting respiratory health awareness | Driver | High | Emergency Therapy |
| Investment in rural healthcare infrastructure | Opportunity | High | Home / Clinic |
| Growing need for pediatric inhalation therapies | Opportunity | Medium | Pediatric Therapy |
| Limited access to inhalation devices in rural areas | Restraint | High | Emergency Therapy |
| High cost of advanced inhalation devices | Restraint | Medium | Corticosteroids |
| Inhalation Therapy Market in India faces challenges due to limited awareness in rural regions | Challenge | High | Outpatient |
| Regulatory hurdles for new inhalation devices can delay market entry | Challenge | Medium | Hospital Supply Chains |
Evaluation of Drivers in India Inhalation Therapy Market (2026–2032)
The factors lifting demand, and the evidence behind each, are summarised below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising asthma prevalence | Long-Term Therapy | Approximately 30 million patients in India require ongoing inhalation therapy, creating a consistent demand for effective treatments. |
| Government health initiatives | Emergency Therapy | The National Health Mission's campaigns improve awareness and treatment access, facilitating increased purchases of inhalation devices. |
| Urban healthcare investments | Home / Clinic | Inhalation therapy is increasingly used in over 80% of senior care facilities, boosting demand for devices. |
| Increased availability of inhalation devices | Pediatric Therapy | Inhalers are widely accessible in over 70% of urban pharmacies, enhancing patient access to necessary treatments. |
| Growing acceptance of combination drugs | Combination Drugs | Combination therapies are gaining traction for effective respiratory management, leading to increased purchases across healthcare facilities. |
Approximately 30 million patients in India require ongoing inhalation therapy, driving demand for effective treatments. Campaigns by the National Health Mission improve awareness and treatment access, particularly in rural areas. Inhalers are widely accessible in over 70% of urban pharmacies, facilitating patient access. The growing acceptance of combination drugs for respiratory management is expected to boost purchases across healthcare facilities.
Evaluation of Restraints in India Inhalation Therapy Market
The key brakes on demand, and where they bite hardest, are shown below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Limited access to inhalation devices in rural areas | Emergency Therapy | Only a fraction of rural pharmacies stock inhalation devices, restricting patient access to essential treatments. |
| High cost of advanced inhalation devices | Corticosteroids | The price of new inhalation devices can be prohibitive for many patients, limiting their treatment options. |
| Lack of awareness about inhalation therapy benefits | Outpatient | Many patients in rural regions remain unaware of effective treatment options, hindering therapy adoption. |
| Regulatory delays for new product approvals | Hospital Supply Chains | New inhalation devices face lengthy approval processes, delaying market entry and affecting hospitals' ability to provide timely care. |
| Inconsistent quality of inhalation products | Pediatric Therapy | Variability in product quality can undermine confidence among healthcare providers, affecting patient outcomes. |
India Inhalation Therapy Market Challenges
The India Inhalation Therapy Market faces notable buyer challenges, particularly the high cost of inhalation devices, which can consume up to 30% of a patient's monthly income. Regulatory hurdles arise from the Central Drugs Standard Control Organization's stringent approval processes, causing delays of up to six months for new products and limiting hospitals' ability to provide timely treatments. Intense competition among suppliers leads to price wars that may compromise product quality, affecting clinics and ultimately hindering effective patient care. Additionally, a skills gap exists in rural areas, where healthcare providers often lack adequate training in inhalation therapy, resulting in poor patient outcomes.
Trends in the India Inhalation Therapy Market
Buyers and suppliers in the India Inhalation Therapy Market are adjusting to the following trends.
- Shift towards Home Care Solutions: Patients are increasingly choosing home care solutions for inhalation therapy, driven by convenience and accessibility. In 2023, over 80% of senior care facilities in India utilised inhalation therapy, reflecting this trend.
- Growth of Combination Therapies: Combination drugs are gaining popularity for managing respiratory conditions, as they offer effective solutions. The market for combination drugs is projected to grow at a CAGR of 8.6% from 2026 to 2032.
- Increased Regulatory Oversight: The Drug Controller General of India updated guidelines for inhalation devices in 2023, ensuring safety and efficacy. This change aims to boost patient trust and compliance with inhalation therapies.
- Rising Awareness Campaigns: The National Health Mission's 'Asthma Control Programme' launched in 2021 has raised awareness about asthma management. This initiative is expected to reach millions, improving treatment adherence.
Investment Opportunities in the India Inhalation Therapy Market
Several openings in the India Inhalation Therapy Market merit attention from investors.
- Local Partnerships for Production: Collaborations with local manufacturers can facilitate the production of inhalation devices, addressing market gaps. The Indian government has allocated ₹500 crores for improving respiratory health infrastructure in rural areas, which can enhance distribution efficiency.
- Investment in Pediatric Care Facilities: There is a growing need for specialised pediatric inhalation therapies, particularly in urban areas. Investing in pediatric clinics can tap into this demand, with a projected growth rate of 8.5% for pediatric therapies.
- Expansion of Rural Healthcare Infrastructure: The Indian government's focus on improving rural healthcare presents an opportunity for suppliers. With a budget of ₹500 crores allocated in 2022, investment in rural facilities can increase access to inhalation therapy.
- Development of Affordable Devices: The demand for cost-effective inhalation devices is rising, especially in lower-income segments. Targeting prescribed outlets can help meet this need, as they serve as primary distribution channels.
Government Initiatives in the India Inhalation Therapy Market
The 'Asthma Control Programme' launched by the National Health Mission in 2021 focuses on improving awareness and treatment accessibility for asthma patients across India. This initiative aims to educate millions about asthma management and ensure better access to inhalation therapies. Additionally, the 'National Programme for Prevention and Control of Respiratory Diseases' approved in 2022 with a budget of ₹500 crores aims to improve respiratory health services nationwide. This funding will support the development of healthcare infrastructure and training for healthcare providers.
The Central Drugs Standard Control Organization oversees the regulation of inhalation therapy products in India. This agency ensures that inhalation devices meet safety and efficacy standards before they are approved for market entry. The Drug Controller General of India also updates guidelines for inhalation devices, ensuring compliance with contemporary medical practices. These measures collectively improve the quality and reliability of inhalation therapies available to patients.
Future Insight of the India Inhalation Therapy Market
The India Inhalation Therapy Market will undergo notable changes by 2032, driven by advancements in nebulizer technology and increased government funding for respiratory health initiatives. The Indian government aims for a 25% reduction in respiratory diseases by 2025, encouraging hospitals to integrate newly approved inhalation devices into their systems. Awareness campaigns led by the Indian Medical Association will improve patient adherence to inhalation therapy, while the implementation of ISO 13485 standards will strengthen quality management in inhalation products, benefiting both buyers and suppliers.
Market Segmentation Analysis
The analysis below covers each segmentation, its leading category in 2025 and its fastest-growing category through 2032.
By Therapy Type – Long-Term Therapy Dominated, Emergency Therapy Expected to Grow Fastest
According to Shubham Deep, Research Manager at 6Wresearch, in 2025, Long-Term Therapy led the therapy type split with a 43% share. Long-Term Therapy captures the largest market share as it is essential for managing chronic respiratory conditions, with approximately 30 million asthma patients in India relying on it. The backing of initiatives like the National Health Mission ensures its widespread adoption and accessibility across healthcare facilities. Emergency Therapy is projected to grow fastest, at a CAGR of 9.3% during 2026–2032. Emergency Therapy is experiencing rapid growth as urban emergency services increasingly integrate nebulizers to address acute respiratory crises. The rising incidence of respiratory emergencies underscores the urgent need for immediate interventions, solidifying this segment's critical role in patient care. Suppliers should focus on enhancing emergency therapy solutions to meet the growing demand in urban healthcare settings.
By Drug Category – Corticosteroids Dominated, Combination Drugs Expected to Grow Fastest
Corticosteroids accounted for a 41% market share by drug category in 2025. Corticosteroids dominate the market share as they are the most commonly prescribed inhalation therapy for managing inflammation associated with respiratory diseases. Their established efficacy and acceptance among healthcare providers reinforce their leading position in the inhalation therapy landscape. Over 2026–2032, Combination Drugs are expected to post the fastest growth, at a CAGR of 8.6%. Combination Drugs are witnessing the fastest growth due to their ability to provide comprehensive management for patients with complex respiratory conditions. This trend is fuelled by an increase in prescriptions aimed at improving treatment adherence and patient outcomes. Buyers should consider the expanding options for combination drugs to ensure effective management of their respiratory health.
By Delivery Setting – Outpatient Dominated, Home / Clinic Expected to Grow Fastest
With a 40% revenue share in 2025, Outpatient was the largest delivery setting category. Outpatient settings capture the largest share as inhalation therapy is widely used for patients managing chronic respiratory conditions outside of hospital environments. This accessibility allows for continuous treatment and monitoring of patients' health. Home / Clinic is set to record the highest CAGR in this split, 8.5% over 2026–2032. Home / Clinic settings are rapidly growing as more patients prefer receiving inhalation therapy in the comfort of their homes, driven by the increasing emphasis on home care solutions. This shift reflects a broader trend towards patient-centric healthcare delivery models. Suppliers must adapt their distribution strategies to cater to the increasing demand for home and clinic-based inhalation therapy solutions.
By Distribution Channel – Hospital Supply Chains Dominated, Pediatric Clinics Expected to Grow Fastest
The largest distribution channel category in 2025 was Hospital Supply Chains, with a 36% share of total revenue. Hospital Supply Chains represent the largest market share as they are crucial for ensuring a steady supply of inhalation therapy products to healthcare facilities. Their established networks facilitate timely access to essential medications for patients requiring immediate treatment. The quickest growth will come from Pediatric Clinics, forecast to expand at a CAGR of 8.5% between 2026 and 2032. Pediatric Clinics are experiencing the fastest growth as there is an increasing focus on specialised care for children with respiratory issues. This growth is bolstered by targeted campaigns aimed at improving treatment adherence among young patients. Suppliers should enhance partnerships with pediatric clinics to capitalise on this growing segment and improve access to inhalation therapy for children.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Inhalation Therapy Market Outlook
- Market Size of India Inhalation Therapy Market, 2025
- Forecast of India Inhalation Therapy Market, 2032
- Historical Data and Forecast of India Inhalation Therapy Revenues & Volume for the Period 2022 - 2032F
- India Inhalation Therapy Market Trend Evolution
- India Inhalation Therapy Market Drivers and Challenges
- India Inhalation Therapy Price Trends
- India Inhalation Therapy Porter's Five Forces
- India Inhalation Therapy Industry Life Cycle
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Therapy Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Long-Term Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Emergency Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Pediatric Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Elderly COPD Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Drug Category for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Corticosteroids for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Fast-Acting Beta Agonists for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Low-Dose Nebulized Meds for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Combination Drugs for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Delivery Setting for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Outpatient for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By ER / Ambulance for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Home / Clinic for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Senior Care Facilities for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Distribution Channel for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Prescribed Outlets for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Hospital Supply Chains for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Pediatric Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of India Inhalation Therapy Market Revenues & Volume By Specialty Drug Providers for the Period 2022 - 2032F
- India Inhalation Therapy Import Export Trade Statistics
- Market Opportunity Assessment By Therapy Type
- Market Opportunity Assessment By Drug Category
- Market Opportunity Assessment By Delivery Setting
- Market Opportunity Assessment By Distribution Channel
- India Inhalation Therapy Top Companies Market Share
- India Inhalation Therapy Competitive Benchmarking By Technical and Operational Parameters
- India Inhalation Therapy Company Profiles
- India Inhalation Therapy Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Therapy Type
- Long-Term Therapy
- Emergency Therapy
- Pediatric Therapy
- Elderly COPD Therapy
By Drug Category
- Corticosteroids
- Fast-Acting Beta Agonists
- Low-Dose Nebulized Meds
- Combination Drugs
By Delivery Setting
- Outpatient
- ER / Ambulance
- Home / Clinic
- Senior Care Facilities
By Distribution Channel
- Prescribed Outlets
- Hospital Supply Chains
- Pediatric Clinics
- Specialty Drug Providers
